Puffy hands and fingers, as well as other symptoms, can precede the “warning sign” of Raynaud’s syndrome as the initial ...

Optometrists can safely perform selective laser trabeculoplasty, with 2.2% of eyes experiencing adverse events, according to ...

Ending adult booster shots for tetanus and diphtheria could save the United States $1 billion a year and eliminate ...

In a draft recommendation statement, the U.S. Preventive Services Task Force said health care professionals should screen all ...

A cancer survivor is working to simplify the cancer care journey for others by using a subway map-style interface to help ...

Mass administration of ivermectin reduced the incidence of malaria by 26% among children during a trial in Kenya, indicating ...

In this video, Philip J. Mease, MD, discusses results from the phase 2 ARGO clinical trials of sonelokimab for psoriatic arthritis, presented at the EULAR 2025 Congress.

In this video, Philip J. Mease, MD, discusses the potential for the development of a T-cell engaging antibody.

In this video, Philip J. Mease, MD, discusses results from phase 3 clinical trials of deucravacitinib for psoriatic arthritis, presented at the EULAR 2025 Congress.

In this video, Philip J. Mease, MD, director of rheumatology research at Providence Swedish Medical Center, in Seattle, discusses results from phase 3b clinical trials of guselkumab.The data, ...

A history of traumatic brain injury was linked to long-term cognitive decline involving speech functions, specifically where ...

Oral upadacitinib may be a promising treatment option for patients with atopic dermatitis-type chronic hand eczema that is ...